当前位置:首页 - 行情中心 - 亚虹医药-U(688176) - 财务分析 - 现金流量表

亚虹医药-U

(688176)

  

流通市值:55.07亿  总市值:72.20亿
流通股本:4.36亿   总股本:5.71亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金73,137,012.47266,180,134.7207,293,835.96128,973,600.82
  收到的税费返还47,772.55430,651.25617,294.54616,911.43
  收到其他与经营活动有关的现金1,393,157.2613,923,143.568,445,392.146,415,390.02
  经营活动现金流入小计74,577,942.28280,533,929.51216,356,522.64136,005,902.27
  购买商品、接受劳务支付的现金15,568,772.3866,770,172.1450,033,446.0723,442,234.18
  支付给职工以及为职工支付的现金80,650,973.57254,646,044.84176,250,462.21131,646,596.19
  支付的各项税费4,985,759.5922,627,477.1218,592,474.5113,285,852.65
  支付其他与经营活动有关的现金97,876,903.75348,283,910.21273,279,040.97161,902,397.65
  经营活动现金流出小计199,082,409.29692,327,604.31518,155,423.76330,277,080.67
  经营活动产生的现金流量净额-124,504,467.01-411,793,674.8-301,798,901.12-194,271,178.4
二、投资活动产生的现金流量:
  收回投资收到的现金480,914,853.111,688,981,498.634,556,531,835.723,331,862,525.65
  处置固定资产、无形资产和其他长期资产收回的现金净额10,901.2814,781.2119,144.052,044.25
  收到的其他与投资活动有关的现金-1,868,8021,868,9841,868,984
  投资活动现金流入小计480,925,754.391,690,865,081.844,558,419,963.773,333,733,553.9
  购建固定资产、无形资产和其他长期资产支付的现金3,726,247.3419,124,958.3912,766,519.159,661,336.13
  投资支付的现金445,000,0001,634,120,0004,605,947,111.113,363,947,111.11
  投资活动现金流出小计448,726,247.341,653,244,958.394,618,713,630.263,373,608,447.24
  投资活动产生的现金流量净额32,199,507.0537,620,123.45-60,293,666.49-39,874,893.34
三、筹资活动产生的现金流量:
  吸收投资收到的现金-8,073,379.498,073,379.49101,191.37
  取得借款收到的现金106,790,000288,046,052.35231,285,966.9167,546,052.35
  筹资活动现金流入小计106,790,000296,119,431.84239,359,346.39167,647,243.72
  偿还债务支付的现金88,096,027.666,200,00036,500,00036,500,000
  分配股利、利润或偿付利息支付的现金1,622,853.714,080,668.477,075,691.921,312,782.07
  支付其他与筹资活动有关的现金5,369,429.0419,675,482.6614,694,877.898,888,680.54
  筹资活动现金流出小计95,088,310.3589,956,151.1358,270,569.8146,701,462.61
  筹资活动产生的现金流量净额11,701,689.65206,163,280.71181,088,776.58120,945,781.11
四、汇率变动对现金及现金等价物的影响-350,302.24-1,679,325.05-385,166.51-308,215.1
五、现金及现金等价物净增加额-80,953,572.55-169,689,595.69-181,388,957.54-113,508,505.73
  加:期初现金及现金等价物余额450,945,370.42620,634,966.11620,634,966.11620,634,966.11
  期末现金及现金等价物余额369,991,797.87450,945,370.42439,246,008.57507,126,460.38
补充资料:
  净利润--432,745,046.85--170,012,214.31
  资产减值准备-7,745.43--24,283.46
  固定资产和投资性房地产折旧-6,765,409.8-3,446,788.72
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-6,765,409.8-3,446,788.72
  无形资产摊销-12,980,853.76-4,317,518.76
  长期待摊费用摊销-2,765,656.4-1,373,406.86
  处置固定资产、无形资产和其他长期资产的损失-610.68--205.5
  固定资产报废损失-2,518.59-2,518.59
  公允价值变动损失--6,822,715.63--3,257,657.52
  财务费用-11,724,507.24-5,619,902.73
  投资损失--15,022,930.99--13,082,697.49
  递延所得税--305,910.69--225,780.58
  其中:递延所得税资产减少--305,910.69--225,780.58
  存货的减少--14,708,285.92--3,874,028.63
  经营性应收项目的减少--68,021,158.59--24,443,047.44
  经营性应付项目的增加-53,987,434.08--21,088,871.63
  其他-17,503,703.51-13,570,049.44
  现金的期末余额-450,945,370.42-507,126,460.38
  减:现金的期初余额-620,634,966.11-620,634,966.11
  现金及现金等价物的净增加额--169,689,595.69--113,508,505.73
公告日期2026-04-302026-04-182025-10-302025-08-29
审计意见(境内)标准无保留意见
TOP↑